Ventas, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ventas, Inc. (NYSE: VTR) on November 14, 2025, reporting events occurring on November 17, 2025. The filing addresses a significant change in executive leadership within the Company's Outpatient Medical & Research division.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the announced retirement of Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, and President and CEO of Lillibridge Healthcare Services, Inc. His retirement is effective as of May 1, 2026. Mr. Bulgarelli will remain in his current role until the effective date to facilitate a comprehensive search for a replacement and ensure an orderly transition of duties.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, outlook, or management commentary regarding future performance. The primary contingency noted is the transition of leadership for the Outpatient Medical & Research segment. The Company has initiated a search for Mr. Bulgarelli's successor.
Investor Verification Checklist
- Verify the exact effective date of Peter J. Bulgarelli's retirement (May 1, 2026).
- Monitor future filings for the appointment of a successor to the Executive Vice President, Outpatient Medical & Research role.
- Review the attached press release (Exhibit 99.1) for additional details on the transition plan.
- Confirm that no other financial or operational metrics were impacted by this announcement in subsequent reports.